De Novo Formation of Insulin-Producing “Neo-β Cell Islets” from Intestinal Crypts

• An in vivo screen for adult tissues amenable to β cell reprogramming
• Robust neoislet formation in intestinal crypts following transient PMN expression
• Reprogramming of glucose-responsive cells that prolong survival in diabetic mice
• Insulin+ cells generated from human intestinal organoids

SummaryThe ability to interconvert terminally differentiated cells could serve as a powerful tool for cell-based treatment of degenerative diseases, including diabetes mellitus. To determine which, if any, adult tissues are competent to activate an islet β cell program, we performed an in vivo screen by expressing three β cell “reprogramming factors” in a wide spectrum of tissues. We report that transient intestinal expression of these factors—Pdx1, MafA, and Ngn3 (PMN)—promotes rapid conversion of intestinal crypt cells into endocrine cells, which coalesce into “neoislets” below the crypt base. Neoislet cells express insulin and show ultrastructural features of β cells. Importantly, intestinal neoislets are glucose-responsive and able to ameliorate hyperglycemia in diabetic mice. Moreover, PMN expression in human intestinal “organoids” stimulates the conversion of intestinal epithelial cells into β-like cells. Our results thus demonstrate that the intestine is an accessible and abundant source of functional insulin-producing cells.

Graphical AbstractFigure optionsDownload as PowerPoint slide